Abstract 4113: Kinase activity based biomarkers: Identification of prognostic and erlotinib response prediction markers in NSCLC patients

MLA

Rob Ruijtenbeek, et al. “Abstract 4113: Kinase Activity Based Biomarkers: Identification of Prognostic and Erlotinib Response Prediction Markers in NSCLC Patients.” Cancer Research, vol. 71, Apr. 2011, p. 4113. EBSCOhost, https://doi.org/10.1158/1538-7445.am2011-4113.

APA

Rob Ruijtenbeek, Robert-Jan van Suylen, Rene van Pel, Petra M. Nederlof, Riet Hilhorst, Eva E. Schaake, Rik de Wijn, Houke M. Klomp, Liesbeth Houkes, Michel van de Heuvel, Victor L. Thijssen, & Anne-Marie C. Dingemans. (2011). Abstract 4113: Kinase activity based biomarkers: Identification of prognostic and erlotinib response prediction markers in NSCLC patients. Cancer Research, 71, 4113. https://doi.org/10.1158/1538-7445.am2011-4113

Chicago

Rob Ruijtenbeek, Robert-Jan van Suylen, Rene van Pel, Petra M. Nederlof, Riet Hilhorst, Eva E. Schaake, Rik de Wijn, et al. 2011. “Abstract 4113: Kinase Activity Based Biomarkers: Identification of Prognostic and Erlotinib Response Prediction Markers in NSCLC Patients.” Cancer Research 71 (April): 4113. doi:10.1158/1538-7445.am2011-4113.